UMIN-ICDS History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000049936
Receipt number R000056873
Scientific Title Efficacy and Safety of Nivolumab+Ipilimumab or Pembrolizumab for Patients with Untreated Advanced or Recurrent Non-small Cell Lung Cancer; A Multicenter Retrospective Observational Study
Date of disclosure of the study information 2022/12/29
Last modified on 2023/03/03 13:21:46

No. Disposal Last modified on Item of update
1 Insert 2022/12/28 13:26:23
2 Update 2023/03/03 13:21:46 Recruitment status
Date of IRB
Anticipated trial start date